Literature DB >> 26282665

Advances in the Treatment of Secondary CNS Lymphoma.

Norbert Schmitz1, Huei Shan Wu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26282665     DOI： 10.1200/JCO.2015.63.1143

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

Authors:  Francisco-Javier Peñalver; Juan-Manuel Sancho; Adolfo de la Fuente; María-Teresa Olave; Alejandro Martín; Carlos Panizo; Elena Pérez; Antonio Salar; Alberto Orfao
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

Review 2.  Central Nervous System Involvement in Peripheral T Cell Lymphoma.

Authors:  Dai Chihara; Yasuhiro Oki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

Review 3.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 4.  Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Authors:  Ashley E Aaroe; Kathryn S Nevel
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.945

5.  Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.

Authors:  Serkan Akin; Chitra Hosing; Issa Khouri; Sairah Ahmed; Amin Alousi; Nathan Fowler; Jacinth Joseph; Jonathan Truxillo; Jeremy L Ramdial; Farzaneh Maadani; Gabriela Rondon; May Daher; Jin S Im; Raphael Steiner; Jason Westin; Swaminathan P Iyer; Bouthaina Dabaja; Paolo Anderlini; Uday R Popat; Muzaffar H Qazilbash; Christopher R Flowers; Elizabeth Shpall; Richard E Champlin; Yago Nieto; Samer A Srour
Journal:  Blood Adv       Date:  2022-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.